COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 1646: Articles 16451-16460  | Next

A simple model for how the risk of pandemics from different virus families depends on viral and human traits
Doelger, J., Chakraborty, A. K., Kardar, M.
10.1101/2021.03.17.21253813 — Posted: 2021-03-24
SARS-CoV-2 prevalence and transmission in swimming activities: results from a retrospective cohort study
Termansen, M. B., Christiansen, A. V., Frische, S.
10.1101/2021.03.19.21253351 — Posted: 2021-03-24
Emergency medicine patient wait time multivariable prediction models: a multicentre derivation and validation study
Walker, K., Jiarpakdee, J., Loupis, A., Tantithamthavorn, C., Joe, K., Ben-Meir, M., Akhlaghi, H., Hutton, J., Wang, W., Stephenson, M., Blecher, G., Buntine, P., Sweeny, A., Turhan, B., Australasian College for Emergency Medicine, Clinical Trial Network (ACEM CTN)
10.1101/2021.03.19.21253921 — Posted: 2021-03-24
Comparative assessment of SARS-CoV-2 serology in healthcare workers with Abbott Architect, Roche Elecsys and The Binding site ELISA immunoassays.
Mohanraj, D., Whitelegg, A., Bicknell, K., Bhole, M., Webber, C., Taylor, L.
10.1101/2021.03.19.21253518 — Posted: 2021-03-24
Longitudinal determination of mRNA-vaccination induced strongly binding SARS-CoV-2 IgG antibodies in a cohort of healthcare workers with and without prior exposure to the novel coronavirus
Korodi, M., Rakosi, K., Jenei, Z., Hudak, G., Horvath, I., Kakes, M., Dallos-Fejer, K., Simai, E., Staver, N., Briciu, V., Lupse, M., Flonta, M., Almas, A., Dana, P., Terza, L.-M., Fejer, S.
10.1101/2021.03.17.21253751 — Posted: 2021-03-24
Increased prevalence of AB group and FY*A red blood cell antigen in Caucasian SARS-CoV-2 convalescent plasma donors
Trepanier, P., Perreault, J., Leiva, G. A., Baillargeon, N., Constanzo Yanez, J., Chevrier, M.-C., Lewin, A.
10.1101/2021.03.17.21253821 — Posted: 2021-03-24
Head-to-head performance comparison of self-collected nasal versus professional-collected nasopharyngeal swab for a WHO-listed SARS-CoV-2 antigen-detecting rapid diagnostic test
Klein, J. A. F., Krüger, L. J., Tobian, F., Gaeddert, M., Lainati, F., Schnitzler, P., Lindner, A. K., Nikolai, O., Knorr, B., Welker, A., de Vos, M., Sacks, J. A., Escadafal, C., Denkinger, C. M.
10.1101/2021.03.17.21253076 — Posted: 2021-03-24
Occupational risk of COVID-19 by country of birth. A register-based study.
Kjollesdal, M. K., Magnusson, K.
10.1101/2021.03.17.21253349 — Posted: 2021-03-24
VIRAL AND ANTIBODY TESTING FOR CORONAVIRUS DISEASE 2019 (COVID-19): FACTORS ASSOCIATED WITH POSITIVITY IN ELECTRONIC HEALTH RECORDS FROM THE UNITED STATES
Lindsay, L., Secrest, M. H., Rizzo, S., Keebler, D., Yang, F., Tsai, L. W.
10.1101/2021.03.19.21253924 — Posted: 2021-03-24
Evaluation of pooling of samples for testing SARS-COV- 2 for mass screening of COVID-19
Mahmoud, D. S., Ibrahim, M. E., Thakre, D. B., Teddy, D. J. G., Raheja, M. P., Ganesan, D. S., Zaher, D. W.
10.1101/2021.03.15.21253567 — Posted: 2021-03-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).